You just read:

Rafaèle Tordjman Launches JEITO CAPITAL, a New Private Equity Company Dedicated to Biotech-biopharmaceuticals, and Announces the Closing of JEITO I at €200 Million

News provided by

JEITO CAPITAL

15 Jan, 2020, 10:02 GMT